Jump to content

Prestige Consumer Healthcare

From Alfawiki
Adapted from the English Wikipedia article Prestige Consumer Healthcare, available under CC BY-SA 4.0Updated 28 November 2025
Prestige Consumer Healthcare Inc.
Company typePublic
IndustryConsumer goods, Healthcare
Founded1996
Headquarters
Tarrytown, New York
,
United States
Key people
Ron Lombardi (CEO and President since June 2015)
ProductsOver-the-counter healthcare and household cleaning products (including Chloraseptic, Clear Eyes, Compound W, Dramamine, Efferdent, Luden's, BC Powder, Goody's Headache Powder, Pediacare, Little Remedies, Beano)
RevenueUS$1.09 billion (2022)
US$329.9 million (2022)
US$205.3 million (2022)
Number of employees
535 (2022)

Prestige Consumer Healthcare Inc. (previously known as Prestige Brands, Inc.) is a U.S.-based enterprise specializing in the marketing and distribution of over-the-counter healthcare and household cleaning items. Established in 1996 through the consolidation of Medtech Products, Prestige Brands International, and the Spic and Span Company, the company is headquartered in Tarrytown, New York and maintains a manufacturing plant located in Lynchburg, Virginia.

Its prominent product lineup features Chloraseptic sore throat remedies, Clear Eyes, wart treatment brand Compound W, motion sickness aid Dramamine, denture care product Efferdent, throat lozenges by Luden's, BC Powder alongside Goody's Headache Powder, children’s OTC lines such as Pediacare and Little Remedies, as well as the dietary supplement Beano (dietary supplement).

In 2022, Prestige reported revenues amounting to US$1.09 billion, with an operating income of US$329.9 million and net earnings of US$205.3 million. The company employed 535 individuals during this period. Since June 2015, Ron Lombardi has held the roles of CEO and president.

History

Founded in 1999 under the name Prestige Brands Holdings, Inc., the company concentrated on acquiring undervalued but reputable brands that were considered non-essential by larger consumer goods corporations. In 2004, private equity firm MidOcean Partners divested Prestige to GTCR Golder Rauner.

Acquisitions

The firm broadened its brand portfolio by purchasing five brands from Blacksmith Brands in 2010.

In December 2011, Prestige acquired 17 brands from GlaxoSmithKline for $660 million, which included notable names such as BC Powder, Beano, Ecotrin, Fiber Choice, Goody's Powder, Sominex, and Tagamet.

The acquisition of Care Pharmaceuticals, an Australian marketer and distributor of OTC healthcare products for both children and adults, took place in 2013.

In 2014, Prestige bought Hydralyte—Australia and New Zealand’s leading oral rehydration solution—from Hydration Pharmaceuticals Trust.

Also during April 2014, the company agreed to purchase Insight Pharmaceuticals Corporation, a marketer specializing in feminine care and other OTC healthcare items, for $750 million in cash.

November 2015 saw Prestige enhance its oral care segment by acquiring DenTek Oral Care Inc. for $225 million in cash.

In December 2016, Prestige purchased C.B. Fleet Co. from Gryphon Investors for around $825 million.

Most recently, in July 2021, it expanded its consumer health portfolio by acquiring assets from Akorn Operating Company, LLC for $228.9 million, which included TheraTears among other products.

Divestitures

Prestige divested its Denorex and Prell shampoo brands in 2009. Subsequently, it sold off Fiber Choice, PediaCare, New-Skin, and Dermoplast in 2016.

In 2018, the company withdrew from the household cleaning products sector through a strategic sale.

Products

The product range of Prestige Consumer Healthcare encompasses a wide array of over-the-counter items distributed across several major categories:

Digestive care

Eye, ear, nose, and throat

Oral care

Pain relief

Pediatric care

Skin care

Sleep aids

Women's health